In a world-first discovery, our scientists have identified a protein that causes liver disease, paving the way for new treatments to be developed.
A large international team of researchers lead by The Westmead Institute for Medical Research in Sydney have found a new genetic variant that puts chronic hepatitis C patients at risk of developing liver disease.
Researchers at the Westmead Institute have designed an easy-to-use clinical tool which can predict the risk of fibrosis progression in patients suffering from liver disease and assist doctors in identifying the best treatment strategies for these patients.
An international research group led by scientists at the Westmead Institute for Medical Research, in developing the first genetic predictor test for liver disease, has discovered a way to determine why some patients develop rapid liver scarring (fibrosis) while others do not.
[Error loading the WebPart 'rptArticles1' of type 'queryrepeater']